Swallowing arsenic? new leukemia pill tested
NCT ID NCT06882031
Summary
This study tested a new oral liquid version of an existing leukemia drug, arsenic trioxide. It involved 12 patients to see how the body absorbs the pill compared to the standard IV infusion, and if taking it with food or an antacid changes that. The goal was to gather data to see if a pill could one day replace IV treatments for this type of cancer.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for ACUTE PROMYELOCYTIC LEUKEMIA (APL) are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
The University of Hong Kong-Clinical Trial Centre Phase 1 Centre
Hong Kong, Hong Kong
Conditions
Explore the condition pages connected to this study.